Showing results (1541-1550 of 2,586) with videos related to

Sort By:
Pageof 259
Molecular Oncology|May 28, 2022
High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE-hypermutated colorectal cancersLoetitia Favre, Justine Cohen, Julien Calderaro, et al.
Molecular Oncology|June 23, 2021
The lncRNA 'UCA1' modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levelsAnaïs Wambecke, Mohammad Ahmad, Pierre-Marie Morice, et al.
Molecular Oncology|July 1, 2021
WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-κB activationYvonne Xinyi Lim, Hexian Lin, Tinghine Chu, et al.
Molecular Oncology|May 14, 2022
Resistance to DNA repair inhibitors in cancerJoseph S Baxter, Diana Zatreanu, Stephen J Pettitt, et al.
Molecular Oncology|May 7, 2022
Lipidomic profiling of exosomes from colorectal cancer cells and patients reveals potential biomarkersMohammed I Y Elmallah, Pablo Ortega-Deballon, Laure Hermite, et al.
Molecular Oncology|January 24, 2018
Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2BMikkel Staberg, Rikke Darling Rasmussen, Signe Regner Michaelsen, et al.
Molecular Oncology|January 10, 2018
Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial statesAndrew Sulaiman, Sarah McGarry, Li Li, et al.
Molecular Oncology|January 10, 2018
A novel enediyne-integrated antibody-drug conjugate shows promising antitumor efficacy against CD30+ lymphomasRong Wang, Liang Li, Shenghua Zhang, et al.
Molecular Oncology|December 7, 2018
Overview of non-coding mutations in chronic lymphocytic leukemiaValeria Spina, Davide Rossi
Molecular Oncology|December 12, 2018
Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycinMiao He, Huizhe Wu, Qian Jiang, et al.
Pageof 259